Skip to main content
. 2022 May 16;18(8):821–830. doi: 10.1038/s41589-022-01024-4

Extended Data Fig. 3. No significant identified molecular signature correlates with MS023 sensitivity in TNBC.

Extended Data Fig. 3

a. Correlation of MTAP expression and MS023 sensitivity. b. Oncoplot showing the mutation status of genes involved in RNA splicing across TNBC cell lines. Color indicates different mutation type. Arrow indicates the sensitivity of cell lines to MS023 treatment. c. PRMT5 gene expression in the Princess Margaret Hospital cell line datasets (PM-Cell lines) datasets. Gene expression is reported as log2(TPM + 0.001). d. PRMT5 protein expression in TNBC cell lines. Arrow indicates the sensitivity of cell lines to MS023 treatment. e. Correlation of cell doubling time and MS023 sensitivity.

Source data